Comparison of chlordecone and estradiol effects on splenic T-cells in (NZB × NZW)F1 mice

Toxicology Letters

Volumn 183, Issue 1-3, 2008, Pages 1-9

  Wang, Fei ^a   Sobel, Eric S ^b   Butfiloski, Edward J ^b   Roberts, Stephen M ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Chlordecone; Estradiol; Organochlorine pesticides; Spleen

Indexed keywords

CHLORDECONE; ESTRADIOL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; MEMORY T LYMPHOCYTE; MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ANIMALS; ANTIGENS, CD4; APOPTOSIS; BODY WEIGHT; CELL PROLIFERATION; CHLORDECONE; ESTRADIOL; ESTROGENS; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED NZB; MICE, INBRED STRAINS; ORGAN SIZE; OVARIECTOMY; PESTICIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 56549084562     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.08.020     Document Type: Article

References (55)

1. Arnold C.N., Campbell D.J., Lipp M., and Butcher E.C. The germinal center response is impaired in the absence of T cell-expressed CXCR5. Eur. J. Immunol. 37 (2007) 100-109
2. Bach J.F. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3 (2003) 189-198
3. Billiau A., Heremans H., Vermeire K., and Matthys P. Immunomodulatory properties of interferon-gamma. An update. Ann. N.Y. Acad. Sci. 856 (1998) 22-32
4. Brennan D.C., Yui M.A., Wuthrich R.P., and Kelley V.E. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J. Immunol. 143 (1989) 3470-3475
5. Buyon J.P., Petri M.A., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., Merrill J.T., Sammaritano L., Lockshin M., Alarcon G.S., Manzi S., Belmont H.M., Askanase A.D., Sigler L., Dooley M.A., Von Feldt J., McCune W.J., Friedman A., Wachs J., Cronin M., Hearth-Holmes M., Tan M., and Licciardi F. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann. Intern. Med. 142 (2005) 953-962
6. Bynoe M.S., Grimaldi C.M., and Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2703-2708
7. Chen J.R., Plotkin L.I., Aguirre J.I., Han L., Jilka R.L., Kousteni S., Bellido T., and Manolagas S.C. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J. Biol. Chem. 280 (2005) 4632-4638
8. Cope A.P. Regulation of autoimmunity by proinflammatory cytokines. Curr. Opin. Immunol. 10 (1998) 669-676
9. Correale J., Arias M., and Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 161 (1998) 3365-3374
10. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol. Lett. 112-113 (2000) 421-432
11. Do Y., Ryu S., Nagarkatti M., and Nagarkatti P.S. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. Toxicol. Sci. 70 (2002) 63-72
12. Dunnett C.W. Pairwise multiple comparisons in the homogeneous variance. J. Am. Stat. Assoc. 75 (2007) 789-795
13. Engleman E.G., Sonnenfeld G., Dauphinee M., Greenspan J.S., Talal N., McDevitt H.O., and Merigan T.C. Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum. 24 (1981) 1396-1402
14. Fehervari Z., and Sakaguchi S. CD4+ Tregs and immune control. J. Clin. Invest. 114 (2004) 1209-1217
15. Gabay C., Cakir N., Moral F., Roux-Lombard P., Meyer O., Dayer J.M., Vischer T., Yazici H., and Gueme P.A. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly lighter than in other rheumatic diseases and correlate with disease activity. J. Rheumatol. 24 (1997) 303-308
16. Gabriel K.R. A simple method of multiple comparisons of means. J. Am. Stat. Assoc. 73 (2007) 364
17. Grimaldi C.M., Hill L., Xu X., Peeva E., and Diamond B. Hormonal modulation of B cell development and repertoire selection. Mol. Immunol. 42 (2005) 811-820
18. Grimaldi C.M., Michael D.J., and Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167 (2001) 1886-1890
19. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23 (2002) 403-408
20. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., and Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179 (1994) 305-310
21. Jacob C.O., van der Meide P.H., and McDevitt H.O. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp. Med. 166 (1987) 798-803
22. Jordan V.C., and Lieberman M.E. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure. Mol. Pharmacol. 26 (1984) 279-285
23. Junt T., Fink K., Forster R., Senn B., Lipp M., Muramatsu M., Zinkernagel R.M., Ludewig B., and Hengartner H. CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses. J. Immunol. 175 (2005) 7109-7116
24. Kamada M., Irahara M., Maegawa M., Yasui T., Takeji T., Yamada M., Tezuka M., Kasai Y., and Aono T. Effect of hormone replacement therapy on post-menopausal changes of lymphocytes and T cell subsets. J. Endocrinol. Invest. 23 (2000) 376-382
25. Kanda N., and Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J. Dermatol. Sci. 38 (2005) 1-7
26. Karpuzoglu-Sahin E., Zhi-Jun Y., Lengi A., Sriranganathan N., and Ansar A.S. Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine 14 (2001) 208-217
27. Klinkhoff A. Biological agents for rheumatoid arthritis: targeting both physical function and structural damage. Drugs 64 (2004) 1267-1283
28. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
29. Krause I., Valesini G., Scrivo R., and Shoenfeld Y. Autoimmune aspects of cytokine and anticytokine therapies. Am. J. Med. 115 (2003) 390-397
30. Lang T.J. Estrogen as an immunomodulator. Clin. Immunol. 113 (2004) 224-230
31. Levene H. Robust tests for equality of variances. In: Olkin I. (Ed). Contributions to Probabilty and Statistics (1960), Stanford University Press, Palo Alto, CA 278-292
32. Levy Y., and Brouet J.C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J. Clin. Invest. 93 (1994) 424-428
33. Li X.Y., Matsuzaki G., Yoshikai Y., Muramori K., and Nomoto K. T cells expressing both L-selectin and CD44 molecules increase in number in peritoneal exudate cells and in vitro-stimulated spleen cells from mice immunized intraperitoneally with Listeria monocytogenes. Immunology 78 (1993) 28-34
34. Llorente L., and Richaud-Patin Y. The role of interleukin-10 in systemic lupus erythematosus. J. Autoimmun. 20 (2003) 287-289
35. Mageed R.A., and Isenberg D.A. Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production. Lupus 11 (2002) 850-855
36. Medina K.L., Smithson G., and Kincade P.W. Suppression of B lymphopoiesis during normal pregnancy. J. Exp. Med. 178 (1993) 1507-1515
37. Merino R., Ding L.Y., Veis D.J., Korsmeyer S.J., and Nunez G. Developmental regulation of the Bcl-2-protein and susceptibility to cell death in B-lymphocytes. EMBO J. 13 (1994) 683-691
38. Ndhlovu L.C., Takeda I., Sugamura K., and Ishii N. Expanding role of T-cell costimulators in regulatory T-cell function: recent advances in accessory molecules expressed on both regulatory and nonregulatory T cells. Crit. Rev. Immunol. 24 (2004) 251-266
39. O'Garra A., Steinman L., and Gijbels K. CD4+ T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9 (1997) 872-883
40. Peeva E., Grimaldi C., Spatz L., and Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J. Clin. Invest. 106 (2000) 1373-1379
41. Petri M., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., Sammaritano L.R., Lockshin M., Merrill J.T., Belmont H.M., Askanase A.D., McCune W.J., Hearth-Holmes M., Dooley M.A., Von Feldt J., Friedman A., Tan M., Davis J., Cronin M., Diamond B., Mackay M., Sigler L., Fillius M., Rupel A., Licciardi F., and Buyon J.P. Combined oral contraceptives in women with systemic lupus erythematosus. N. Engl. J. Med. 353 (2005) 2550-2558
42. Polanczyk M.J., Carson B.D., Subramanian S., Afentoulis M., Vandenbark A.A., Ziegler S.F., and Offner H. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J. Immunol. 173 (2004) 2227-2230
43. Richards H.B., Satoh M., Jennette J.C., Croker B.P., Yoshida H., and Reeves W.H. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int. 60 (2001) 2173-2180
44. Rijhsinghani A.G., Thompson K., Bhatia S.K., and Waldschmidt T.J. Estrogen blocks early T cell development in the thymus. Am. J. Reprod. Immunol. 36 (1996) 269-277
45. Roubinian J.R., Talal N., Greenspan J.S., Goodman J.R., and Siiteri P.K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 147 (1978) 1568-1583
46. Sandborg C. Expression of autoimmunity in the transition from childhood to adulthood: role of cytokines and gender. J. Adolesc. Health 30 (2002) 76-80
47. Selvaraj V., Bunick D., Finnigan-Bunick C., Johnson R.W., Wang H., Liu L., and Cooke P.S. Gene expression profiling of 17beta-estradiol and genistein effects on mouse thymus. Toxicol. Sci. 87 (2005) 97-112
48. Shokat K.M., and Goodnow C.C. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375 (1995) 334-338
49. Smeets J.M., van Holsteijn I., Giesy J.P., Seinen W., and van den B.M. Estrogenic potencies of several environmental pollutants, as determined by vitellogenin induction in a carp hepatocyte assay. Toxicol. Sci. 50 (1999) 206-213
50. Sobel E.S., Gianini J., Butfiloski E.J., Croker B.P., Schiffenbauer J., and Roberts S.M. Acceleration of autoimmunity by organochlorine pesticides in (NZB × NZW)F1 mice. Environ. Health Perspect. 113 (2005) 323-328
51. Takao T., Kumagai C., Hisakawa N., Matsumoto R., and Hashimoto K. Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes. J. Endocrinol. 184 (2005) 191-197
52. Telford W.G., King L.E., and Fraker P.J. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif. 24 (1991) 447-459
53. Wang F., Roberts S.M., Butfiloski E.J., Morel L., and Sobel E.S. Acceleration of autoimmunity by organochlorine pesticides: a comparison of splenic B-cell effects of chlordecone and estradiol in (NZB×NZW)F1 mice. Toxicol. Sci. 99 (2007) 141-152
54. Wang F., Roberts S.M., Butfiloski E.J., and Sobel E.S. Diminished prolactin from chlordecone treatment in ovariectomized (NZB×NZW)F(1) mice. Int. Immunopharmacol. 7 (2007) 1808-1812
55. Whitacre C.C., Reingold S.C., and O'Looney P.A. A gender gap in autoimmunity. Science 283 (1999) 1277-1278